论文部分内容阅读
■全球禽流感疫情暴发,公司在抗禽流感新药的研制上获得突破。■最近几个月股价在相对高位震荡,由于业绩大增,未来可能向上突破。■公司各项产品盈利能力提升,禽流感新药研制取得突破,未来大幅增长可期。■当前股价:5.11元,目标价位:6.50-7.00元。强买。
■ The global outbreak of bird flu has led to a breakthrough in the development of new anti-bird flu medicine. ■ In recent months, the share price has been fluctuating at a relatively high level and due to the substantial increase in performance, the stock market may break up in the future. ■ The profitability of various products of the Company has been increased. Breakthroughs have been made in the development of a new drug for bird flu, and the substantial increase in the future can be expected. ■ Current share price: 5.11 yuan, the target price: 6.50-7.00 yuan. Strong buy.